• Explore /
  • Poster
  • / Neoadjuvant chemotherapy is associated with improved outcomes in patients with stage 1A and 1B pancreatic cancer undergoing surgery: An NCDB study.

Neoadjuvant chemotherapy is associated with improved outcomes in patients with stage 1A and 1B pancreatic cancer undergoing surgery: An NCDB study.

Abstract Poster

Authors

null

Noah Rozich

Aurora St. Luke's Medical Center, Milwaukee, WI

Noah Rozich , Maharaj Singh , Isaac Kriley , James L. Weese , Aaron Chevinsky FACS , Wesley Allan Papenfuss , Geoffrey Bellini

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 4157)

DOI

10.1200/JCO.2022.40.16_suppl.4157

Abstract #

4157

Poster Bd #

142

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Neoadjuvant chemotherapy vs upfront resection: A challenging choice in resectable pancreatic ductal adenocarcinoma.

Neoadjuvant chemotherapy vs upfront resection: A challenging choice in resectable pancreatic ductal adenocarcinoma.

First Author: Fatemeh Fekrmandi

First Author: Fang Liu

First Author: Michiaki Unno

First Author: Amit Jethanandani